Advertisement

Topics

Latest "Odonate Therapeutics, Inc." News Stories

02:19 EDT 19th August 2018 | BioPortfolio

Here are the most relevant search results for "Odonate Therapeutics, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Odonate Therapeutics, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Odonate Therapeutics, Inc. for you to read. Along with our medical data and news we also list Odonate Therapeutics, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Odonate Therapeutics, Inc. Companies for you to search.

Showing "Odonate Therapeutics" News Articles 1–25 of 7,400+

Saturday 18th August 2018

Week in Review: Shanghai ChemPartner, a China CRO/CMO, Completes Reverse Merger

Deals and Financings  Shanghai ChemPartner, a CRO/CMO, closed its reverse merger with Quantum Hi-Tech China Biological at an undisclosed valuation;  YiChang HEC ChangJiang Pharm raised $400 million from Blackstone Group via a convertible bond offering representing a 15% share in HEC; The Buck Institute for Research on Aging, Insilico and Juvenescence joined together to form Napa Therape...


Mycobacterium tuberculosis Infections Global Clinical Trials Review, H1, 2018 [Report Updated: 30032018] Prices from USD $2500

Mycobacterium tuberculosis Infections Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical trial report, Mycobacterium tuberculosis Infections Global Clinical Trials Review, H1, 2018" provides an overview of Mycobacterium tuberculosis Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Mycobacterium tuberculosis Infections. Repo...

Hereditary Angioedema HAE C1 Esterase Inhibitor [C1INH] Deficiency Pipeline Review, H1 2018 [Report Updated: 12062018] Prices from USD $2000

Hereditary Angioedema HAE C1 Esterase Inhibitor [C1INH] Deficiency Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hereditary Angioedema HAE C1 Esterase Inhibitor [C1INH] Deficiency Pipeline Review, H1 2018, provides an overview of the Hereditary Angioedema HAE C1 Esterase Inhibitor [C1INH] Deficiency Immunology pipeline landscap...


Sangamo Therapeutics: More Catalysts Powering A Gene-Based Innovator

Windtree Therapeutics Inc WINT Financial and Strategic SWOT Analysis Review [Report Updated: 13062018] Prices from USD $125

Windtree Therapeutics Inc WINT Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that aug...

Optic Neuritis Pipeline Review, H1 2018 [Report Updated: 24042018] Prices from USD $2000

Optic Neuritis Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Optic Neuritis Pipeline Review, H1 2018, provides an overview of the Optic Neuritis Ophthalmology pipeline landscape.Optic neuritis is an inflammation of the optic nerve, the bundle of nerve fibers that transmits visual information from eye to brain. Symptoms include ...

Aspyrian Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12042018] Prices from USD $250

SummaryAspyrian Therapeutics Inc Aspyrian Therapeutics is a clinical stage biotechnology company that develops firstinclass precision targeted cancer drugs for the treatment of solid tumors. The company harnesses the Photoimmunotherapy PIT platform to develop its products. Its lead pipeline product candidate, RM1929, an antibody conjugate of cetuximab and IRDye 700DX, targeting epidermal growth fa...

Aminopeptidase N Myeloid Plasma Membrane Glycoprotein CD13 or Alanyl Aminopeptidase or Aminopeptidase M or Microsomal Aminopeptidase or gp150 or CD13 or ANPEP or EC 3.4.11.2 Pipeline Review, H1 2018 [Report Updated: 08052018] Prices from USD $3500

Aminopeptidase N Myeloid Plasma Membrane Glycoprotein CD13 or Alanyl Aminopeptidase or Aminopeptidase M or Microsomal Aminopeptidase or gp150 or CD13 or ANPEP or EC 3.4.11.2 Pipeline Review, H1 2018SummaryAccording to the recently published report 'Aminopeptidase N Pipeline Review, H1 2018'; Aminopeptidase N Myeloid Plasma Membrane Glycoprotein CD13 or Alanyl Aminopeptidase or Aminopeptidase M o...

Acute Renal Failure ARF Acute Kidney Injury Pipeline Review, H2 2018 [Report Updated: 17072018] Prices from USD $2000

Acute Renal Failure ARF Acute Kidney Injury Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure ARF Acute Kidney Injury Pipeline Review, H2 2018, provides an overview of the Acute Renal Failure ARF Acute Kidney Injury Genito Urinary System And Sex Hormones pipeline landscape.Acute kidney failure occurs when kidney...

Juventas Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23042018] Prices from USD $250

SummaryJuventas Therapeutics Inc Juventas, formerly AcelleRX Therapeutics Inc is a clinical stage biotechnology company that develops regenerative therapies to treat life threatening cardiovascular diseases. The company specializes in the development of novel therapies for ischemic cardiovascular disease. Its pipeline products include a natural chemokine that is overexpressed in response to tissue...

BrainStorm Cell Therapeutics Inc BCLI Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11072018] Prices from USD $250

SummaryBrainStorm Cell Therapeutics Inc BrainStorm Cell Therapeutics formerly Golden Hand Resources Inc is a biotechnology company which develops autologous stem cell therapies for neurodegenerative diseases. Its pipeline mesenchymal stem cell products are being developed based on cell therapy platform NurOwn, customized for the treatment of multiple sclerosis, amyotrophic lateral sclerosis, parki...

Pheochromocytoma Global Clinical Trials Review, H1, 2018 [Report Updated: 28052018] Prices from USD $2500

Pheochromocytoma Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical trial report, Pheochromocytoma Global Clinical Trials Review, H1, 2018" provides an overview of Pheochromocytoma clinical trials scenario. This report provides top line data relating to the clinical trials on Pheochromocytoma. Report includes an overview of trial numbers and their average enrollment in top countri...

Miragen Therapeutics Inc MGEN Medical Equipment Deals and Alliances Profile [Report Updated: 12072018] Prices from USD $250

SummaryMiragen Therapeutics, Inc. Miragen, formerly Signal Genetics Inc, is a clinical stage biopharmaceutical company. It discovers and develops RNAtargeted therapeutics with a focus on microRNAs and their role in diseases. The company's product candidates, MRG106 and MRG201 are in Phase 1 clinical trials. Miragen's clinical product candidate for the treatment of certain cancers, MRG106, is an in...

Leap Therapeutics Inc LPTX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06072018] Prices from USD $250

SummaryLeap Therapeutics Inc Leap Therapeutics, formerly HealthCare Pharmaceuticals Inc, is a clinicalstage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The company's pipeline products include DKN01, a humanized monoclonal antibody that targets the Dickkopf1 DKK1 protein, intended for the treatment of gastroesophageal cancer, biliary tract cancer, hepat...

#jobs #lifescience Head of Translational Research

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Head of Translational Research .MA-Cambridge, Clinical-stage, well-funded biotech company with -75 employees in N. Cambridge impacting life-altering diseases through novel immunology therapeutics is hiring their first Head of … Continue reading → Cet article #jobs ...

Globoid Cell Leukodystrophy Krabbe Disease Pipeline Review, H1 2018 [Report Updated: 12062018] Prices from USD $2000

Globoid Cell Leukodystrophy Krabbe Disease Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Globoid Cell Leukodystrophy Krabbe Disease Pipeline Review, H1 2018, provides an overview of the Globoid Cell Leukodystrophy Krabbe Disease Central Nervous System pipeline landscape.Krabbe disease also called globoid cell leukodystrophy is ...

Hemochromatosis Pipeline Review, H1 2018 [Report Updated: 29052018] Prices from USD $2000

Hemochromatosis Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hemochromatosis Pipeline Review, H1 2018, provides an overview of the Hemochromatosis Genetic Disorders pipeline landscape.Hemochromatosis is an iron disorder in which the body simply loads too much iron. Symptoms include joint pain, abdominal pain, fatigue, weakness...

Vasomotor Symptoms of Menopause Hot Flashes Global Clinical Trials Review, H1, 2018 [Report Updated: 25042018] Prices from USD $2500

Vasomotor Symptoms of Menopause Hot Flashes Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical trial report, Vasomotor Symptoms of Menopause Hot Flashes Global Clinical Trials Review, H1, 2018" provides an overview of Vasomotor Symptoms of Menopause Hot Flashes clinical trials scenario. This report provides top line data relating to the clinical trials on Vasomotor Symptoms of Men...

Glutamate Receptor Ionotropic NMDA 2B Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B Pipeline Review, H2 2018 [Report Updated: 10072018] Prices from USD $3500

Glutamate Receptor Ionotropic NMDA 2B Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B Pipeline Review, H2 2018SummaryAccording to the recently published report 'Glutamate Receptor Ionotropic NMDA 2B Pipeline Review, H2 2018'; Glutamate Receptor Ionotropic NMDA 2B Glutamate [NMDA] Receptor Subunit Epsilon...

Hidradenitis Suppurativa Pipeline Review, H2 2018 [Report Updated: 17072018] Prices from USD $2000

Hidradenitis Suppurativa Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hidradenitis Suppurativa Pipeline Review, H2 2018, provides an overview of the Hidradenitis Suppurativa Dermatology pipeline landscape.Hidradenitis suppurativa is a chronic skin condition that features peasized to marblesized lumps under the skin. Also known...

TG Therapeutics Is Worth A Look Before Phase 3 Combination Cancer Data

Friday 17th August 2018

Halozyme Therapeutics Inc HALO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 16042018] Prices from USD $250

SummaryHalozyme Therapeutics Inc Halozyme is a biotechnology company focusing on the development and commercialization of novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company's products portfolio depends on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes affe...

Knight Therapeutics Inc GUD Medical Equipment Deals and Alliances Profile [Report Updated: 12072018] Prices from USD $250

SummaryKnight Therapeutics Inc Knight Therapeutics is a pharmaceutical company that offers acquisition, inlicensing, selling and marketing of prescription and over the counter pharmaceutical products. The company's pipeline products include prescription drugs, consumer health products, and medical devices. Its consumer health products are used in the treatment of metabolic diseases, dermatological...

Nasal Congestion Global Clinical Trials Review, H1, 2018 [Report Updated: 30032018] Prices from USD $2500

Nasal Congestion Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical trial report, Nasal Congestion Global Clinical Trials Review, H1, 2018" provides an overview of Nasal Congestion clinical trials scenario. This report provides top line data relating to the clinical trials on Nasal Congestion. Report includes an overview of trial numbers and their average enrollment in top countri...

Prostate Cancer Pipeline Review, H1 2018 [Report Updated: 29062018] Prices from USD $2500

Prostate Cancer Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer Pipeline Review, H1 2018, provides an overview of the Prostate Cancer Oncology pipeline landscape.Prostate cancer is a form of cancer that affects men and starts off in the prostate gland. Prostate cancer usually occurs in older men. Symptoms include ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks